Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Formulation including a combination of beta-endorphin and adrenocorticotropic hormone

US Patent 11285192 · Granted Mar 29, 2022

Estimated economic value: $2,196,000

Assignee

Inventors

View full patent text on Google Patents →